Table 1 The study population characteristics.
Variable | Value |
|---|---|
Male/Female, n (%) | 18 (58%)/13 (42%) |
Age, mean (± SD), [years] | 54 (± 14) |
Severity of disease: | |
APACHE II, median (IQR), [points] | 11 (6–14) |
SAPS II, median (IQR), [points] | 33 (26–40) |
SOFA, median (IQR), [points] | 6 (2–8) |
Factors having potential impact on sleep quality: | |
Isolation room, n (%) | 8 (26%) |
Opioids, n (%) | 10 (32%) |
Antiepileptic drugs, n (%) | 9 (29%) |
Sleep-promoting medications, n (%) | 7 (23%) |
Antidepressants, n (%) | 6 (19%) |
Antipsychotics, n (%) | 6 (19%) |
Benzodiazepines, n (%) | 5 (16%) |
Mechanical ventilation, n (%) | 4 (13%) |
Hydroxyzine, n (%) | 2 (7%) |
Delirium, n (%) | 2 (7%) |
Metoclopramide, n (%) | 1 (3%) |
